GT Biopharma (OXIA.F) Q2 2025 Earnings

15MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-2.56
-1.81
-1.05
-0.29

Details

Expected EPS
-0.2948814
Actual EPS
-0.2948814
Surprise EPS
0
Surprise Percent
+0%

Description

GT Biopharma (OXIA.F) has reported earnings of -0.2948814 per share for Q2 2025.

0 Comments

Share your thoughts